Long-Term Clinical Effectiveness of Ustekinumab in Patients With Crohn's Disease: A Retrospective Cohort Study.
Takahiro ItoAtsuo MaemotoTakehiko KatsuradaHiroki TanakaSatoshi MotoyaNobuhiro UenoMikihiro FujiyaToshifumi AshidaDaisuke HirayamaHiroshi NakasePublished in: Crohn's & colitis 360 (2020)
Ustekinumab is effective and persistent in CD patients with the previous treatment history of several biologics.